Recent Advances in Biotech

Recent Advances in Biotech

RELEASE DATE
15-Dec-2017
REGION
Global
Research Code: D758-00-65-00-00
SKU: HC02939-GL-TA_21264

$250.00

Special Price $187.50 save 25 %

In stock
SKU
HC02939-GL-TA_21264

$250.00

$187.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends. Precision clinical trial studies, glucose monitoring through smartphones, and gene editing to modify epigenetics are illustrated in the TOE.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Clinical trials, glucose monitoring, smart healthcare, gene editing, CRISPR, epigenetics

Table of Contents

Recent Diagnostic and Biopharma Advances

  • Advancing Precision Clinical Trial Studies
  • Novel Smartphone Case for Monitoring Blood Glucose
  • Modifying CRISPR Platform for Epigenetic Applications
  • Gilead, Kite Set to Acquire Cell Design Labs

Clinical Trial Analysis and Industry Interactions

  • Summary of Key Clinical Studies Conducted by Sanguine Biosciences and Salk Institute
  • Summary of Key Contacts
Related Research
This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends. Precision clinical trial studies, glucose monitoring through smartphones, and gene editing to modify epigenetics are illustrated in the TOE. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Clinical trials, glucose monitoring, smart healthcare, gene editing, CRISPR, epigenetics
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D758-00-65-00-00
Is Prebook No